Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kolb

Showing results (11-20 of 278) with videos related to

Pageof 28
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 2, 2016
Pathways to Precision Medicine in Idiopathic Pulmonary Fibrosis. Time to Relax?Nathan Hambly, Martin Kolb
The European Respiratory Journal|February 2, 2023
Nintedanib in chILD: a small step, yes… but at least a step forward in a marathon!David Gozal, Martin Kolb
The European Respiratory Journal|May 19, 2023
A novel take on idiopathic pulmonary fibrosis disease progression: localised autoimmunityManali Mukherjee, Martin Kolb
The European Respiratory Journal|January 28, 2022
The evolution of the <i>European Respiratory Journal</i>: adapting in an era of changeJames D Chalmers, Martin Kolb
American Journal of Respiratory and Critical Care Medicine|December 16, 2014
Fibrocytes and progression of fibrotic lung disease. Ready for showtime?Bethany B Moore, Martin Kolb
The European Respiratory Journal|January 20, 2018
The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?Christopher J Ryerson, Martin Kolb
Thorax|December 19, 2015
Interstitial lung disease: time to rethink the snapshot diagnosis?Danielle Antin-Ozerkis, Martin Kolb
The European Respiratory Journal|February 6, 2025
Drug-induced lung disease: unwanted collateral damageYet H Khor, Martin Kolb
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2014
Staging of idiopathic pulmonary fibrosis: past, present and futureMartin Kolb, Harold R Collard
The European Respiratory Journal|January 19, 2019
The evolution of the <i>European Respiratory Journal</i>: volume 2James D Chalmers, Martin Kolb
Pageof 28

Showing results (11-20 of 278) with videos related to

Sort By:
Pageof 28
American Journal of Respiratory and Critical Care Medicine|December 2, 2016
Pathways to Precision Medicine in Idiopathic Pulmonary Fibrosis. Time to Relax?Nathan Hambly, Martin Kolb
The European Respiratory Journal|February 2, 2023
Nintedanib in chILD: a small step, yes… but at least a step forward in a marathon!David Gozal, Martin Kolb
The European Respiratory Journal|May 19, 2023
A novel take on idiopathic pulmonary fibrosis disease progression: localised autoimmunityManali Mukherjee, Martin Kolb
The European Respiratory Journal|January 28, 2022
The evolution of the <i>European Respiratory Journal</i>: adapting in an era of changeJames D Chalmers, Martin Kolb
American Journal of Respiratory and Critical Care Medicine|December 16, 2014
Fibrocytes and progression of fibrotic lung disease. Ready for showtime?Bethany B Moore, Martin Kolb
The European Respiratory Journal|January 20, 2018
The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?Christopher J Ryerson, Martin Kolb
Thorax|December 19, 2015
Interstitial lung disease: time to rethink the snapshot diagnosis?Danielle Antin-Ozerkis, Martin Kolb
The European Respiratory Journal|February 6, 2025
Drug-induced lung disease: unwanted collateral damageYet H Khor, Martin Kolb
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2014
Staging of idiopathic pulmonary fibrosis: past, present and futureMartin Kolb, Harold R Collard
The European Respiratory Journal|January 19, 2019
The evolution of the <i>European Respiratory Journal</i>: volume 2James D Chalmers, Martin Kolb
Pageof 28